Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Genosco logo — Turning unseen possibility into reality through innovative s...

Genosco

Turning unseen possibility into reality through innovative science

Founded 2008 United States Billerica, United States 26 employees Biotechnology

General Information

Company Name Genosco
Founded Year 2008
Location United States Billerica, United States +1
Employees 26
Industries Biotechnology
Social

Get notified when Genosco moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Genosco

Genosco is a clinical-stage biotech company founded in 2008, with the slogan "Turning unseen possibility into reality through innovative science." The company focuses on the discovery and development of novel small-molecule drugs for patients with unmet medical needs. Genosco's proprietary G-SMART™ platform enables the discovery and optimization of rare sequences in protein kinases, leading to the development of highly selective compounds. The company has a strong portfolio of multiple independent and partnered pipelines, with its most advanced pipeline, Lazertinib, currently undergoing a phase 3 global clinical trial by Janssen and available in Korea for patients with EGFRm+ non-small cell lung cancer. The team, consisting of scientists with deep expertise in medicinal chemistry, structural & computational drug discovery design, cell biology, pharmacology, and drug metabolism, works with a mission to enhance people's lives through innovative science. Genosco's innovative approach and robust research and discovery programs position it as a key player in the biotechnology industry. The company is headquartered in the United States. As of now, there is no publicly disclosed information about the last investment and the involved investors. With its focus on precision medicine and a commitment to improving healthcare, Genosco presents an exciting opportunity for investors looking to support groundbreaking advancements in biotechnology.

Taxonomy: biotech, small-molecule drugs, clinical-stage, precision medicine, protein kinases, drug discovery, EGFRm+ non-small cell lung cancer, phase 3 clinical trial, Janssen partnership, medicinal chemistry, selective kinase inhibitors, structural biology, pharmacology, interdisciplinary team, innovative science

No funding data available for Genosco yet.

Get notified when Genosco raises funding

Genosco Alternatives & Competitors

Genosco vs
Genelux
Genelux United States

Genelux Corporation (NASDAQ: GNLX) is a late clinical-stage biotechnology company focused on improvi...

Post Ipo Equity
34 employees
Biopharma, Biotechnology
Genosco vs
Curis
Curis United States

Working relentlessly to develop innovative and differentiated therapeutics that improve the lives of...

Post Ipo Equity
133 employees
Biotechnology, Health Care
Genosco vs
CELLIPSE
CELLIPSE

CELLIPSE is a drug discovery company based in Grenoble, France dedicated to bringing innovative ther...

2-10 employees
Biotechnology, Health Care

FAQ About Genosco

Turning unseen possibility into reality through innovative science
Genosco was founded in 2008.
Genosco is headquartered in Billerica, United States.
Genosco operates in the following industries: Biotechnology.
Genosco has approximately 26 employees.
Top alternatives and competitors to Genosco include Genelux, Curis, CELLIPSE, RAPT Therapeutics, Alaunos Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Genosco and Genelux are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Genosco and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy